Group B Strep(GBS) infusions cause acute P-HTN in several animal models. This response includes increased pulmonary artery pressure (Ppa), and resistance (PVR), and decreased pulmonary flow; systemic flows are often decreased. We infused a bolus of PNEU in 2, <2-wk-old, acutely-operated, anesthetized lambs and found that P-HTN occurred. We then studied this effect in 2 unanesthetized, chronically-instrumented piglets, <1 mo. old. Infused bacteria were heat-killed, washed and resuspended in buffer. The pigs received 1 item/day at 3-4.5 X l o 9 particles/dose. Qualitatively similar severe P-HTN resulted from bolus infusions of all PNEU strains tested (PI, P14, and P23) also from Group E , Group G , a n d a nontypeable Group B Strep, Staph aureus, and zymosan. Agitation, cyanosis, systemic hypotension, bradycardia and seizures also occurred. Latex particles, similar size a s bacteria, had no effect at this dose. A mild, transient rise in Ppa and PVR was noted after a double dose, suggesting that a quantity of particles alone doesn't produce the same P-HTN. Indomethacin blocked the P-HTN caused by PNEU. We conclude that P-HTN is a nonspecific host response that can be elicited by a variety of GM+ bacteria. Agent(s) that may trigger the response are not unique to GBS or endotoxin. Cyclooxygenase pathway products appear to mediate this P-HTN which may be clinically important in shock occurrine with GM+ infections. The American Academy of Pediatrics (AAP) Red Book calls for beginning R prophylaxis of Hib index cases prior to discharge from hospital. We randomized invasive Hib index cases into two groups: Group 1 (GI) received R 20 mg/kg/day x 4d concomitant with the last 4 days of systemic therapy; Group 2 (G2) received R the four days following systemic therapy. Throat cultures (TC) for Hib were obtained in all families not prophylaxed under AAP guidelines and in most members after empiric R; Hib positive contacts were treated with R to minimize index case reacquisition of Hib after hospital discharge. TC were obtained from index cases and most household members 5-16 days after R therapy. To date 33 children have been enrolled in the study and followup is complete in 29. Stools were negative for other parasites and for Shigella, Salmonella, and Campylobacter organisms.
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ELIMINATION OF HEMOPHILUS
None o f t h e children had a history o f animal exposure, and mode o f acquisition could not be determined.
Two children attended different day c a r e centers.
Cryptosporidium may be an important c a u s e o f diarrhea in normal children.
Further studies are necessary t o determine its exact role in diarrheal disease.
ilarities. In both diseases a diffuse vascular involvement with little acute inflammatory reaction occurs, with necrosis and fibrin exudation in and around vessel walls.
We suggested that Pseudomonas sepsis might play a role in the pathogenesis of KD. We embarked on a series of experimental investigations aiming at the production of a disease process similar to KD by infecting animals with Pseudomonas bacilli (mucoid and non-mucoid strains).
Treatment of mice and guinea-pigs previously infected with lo8 organisms intra-peritoneally with either nitrogen-mustard or cyclophosphamide produced a slow disease. At the end of the second week, these animals exhibited severe vasculitis with little inflammatory reaction. Dilatation of blood vessels and formation of coronary aneurysms were obtained similar to the histological findings in patients with KD.
It is proposed that Pseudomonas aeruginosa infection in immunologically deficient animals, can mimic KD and a similar mechanism might be effective in the naturally occurring disease. Groups of breast-feeding and non-breast (bottle) feeding mothers who were seronegative for rubella virus during pregnancy were immunized with subcutaneously administered live rubella virus vaccine during the immediate post-partum period. All infants of these women were subsequently immunized at 15 months of age with live measles, mumps and rubella vaccine. The rubella antibody activity in the mothers and the infants was determined by standard hemagglutination inhibition (HAI) test and enzymelinked immunoassa: (ELISA, IgG) before and six months after immunization. All infants developed significant rubella specific HA1 and ELISA antibody response. The mean antibody titers in bottle-fed infants (HA1 77, ELISA 7961) were higher than breastfed infants (HA1 69, ELISA 6400), although the difference was not statistically significant (P>0.05). These observations suggest that although shedding of infectious rubella vaccine virus in the breast milk has been associated with post-partum immunization of seronegative women, acquisition of the virus by the infants in the neonatal period does not appear to have significant adverse influence on the success of routine rubella immunization at 15 months of age. The importance of the subtle differences observed here remains to be defined.
